Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02106091
Title Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Affimed GmbH
Indications

B-cell lymphoma

lymphoplasmacytic lymphoma

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

AFM11

Age Groups: adult | senior
Covered Countries USA | DEU


No variant requirements are available.